Assessment of the Perceptions and Opinions of Staff Working of Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction (PERRCEP) (PERRCEP)

March 24, 2025 updated by: University Hospital, Brest

Assessment of the Perceptions and Opinions of Staff Working in Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction

Evaluation, through an anonymous questionnaire, of the perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures in prison environment. The secondary objective of the study will be to assess training needs and explore factors associated with better adherence to the implementation of harm reduction measures.

Study Overview

Status

Active, not recruiting

Detailed Description

A first contact will be made by email with the heads of institutions, directors of Penitentiary Rentegration Services), and coordinating doctors of healthcare units to inform them about the study's objectives and procedures, and to request their institution's and service's participation.

If they agree to participate, volunteer key contacts will be identified in each institution to relay the information to the staff working in the institution and ensure the distribution of the questionnaire.

The study's responsible doctor will meet with one of the resident investigators for a preliminary informational meeting with the institution's director, the SPIP director, and the identified key staff members. The questionnaires will be handed to the key contacts at that time.

A "non-opposition" letter will be individually distributed with each anonymous questionnaire to provide further details about the study for which their participation is requested.

After answering, participants will be able to place the questionnaire in the provided envelope, and then into a sealed ballot box.

After the answering period, the investigator will go back to prisons and detention centers to collect the ballot boxes.

The data from each paper questionnaire will be transcribed by the residents onto an online platform using the Lime Survey® software.

The statistician of UBO (university of Brest) will have access to the data on Lime Survey® in order to perform the statistical analyses as described below.

The statistician will make a descriptive analysis of the results and the an analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age

Study Type

Observational

Enrollment (Estimated)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brest, France, 29200
        • CHU Brest

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, and detention center of Lorient and Rennes :

  • healthcare staff, divided into 5 sectors : somatic, psychiatric, odontology, addictology, pharmacy)
  • prison warders
  • Reintegration support service (in french : Service pénitentiaire d'insertion et de probation)
  • other prison staff

Description

Inclusion Criteria:

  • working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, who has answered the questionnaire
  • working person of detention center of Lorient and Rennes, who answered the questionnaire

Exclusion Criteria:

  • person opposing participation in the study
  • person under legal protection measure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures.
Time Frame: from january 2025 to may 2025
descriptive analysis of the results
from january 2025 to may 2025

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess training needs and research factors associated with improved adherence to harm reduction mesures
Time Frame: from january 2025 to may 2025
An analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age.
from january 2025 to may 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Estimated)

May 1, 2025

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

March 19, 2025

First Submitted That Met QC Criteria

March 24, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 29BRC24.0333 - PERRCEP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected data that underlie results in a publication

IPD Sharing Time Frame

Data will be available beginning three years and ending fifteen years following the final study report completion

IPD Sharing Access Criteria

Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Harm Reduction

Subscribe